Previous analysis of this patient identified several consecutive mutations that lead to upregulated MAPK signaling by different mutations including, including copy number gain of BRAF in the AC precursor and loss of heterozygosity for the NRAS G12D mutation in melanoma genotype A (Fig. 7c)55. The gene discussed is NRAS; the disease is melanoma.